Callum Jeannie L, Cohen Robert, Cressman Alex M, Strauss Rachel, Armali Chantal, Lin Yulia, Pendergrast Jacob, Lieberman Lani, Scales Damon C, Skeate Robert, Ross Heather, Cserti-Gazdewich Christine
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Transfusion. 2018 Sep;58(9):2139-2148. doi: 10.1111/trf.14820.
Transfusion-associated circulatory overload (TACO) is a leading cause of serious reactions. In regard to TACO, little is known regarding biomarkers as a predictor, their most informative timing, or thresholds of significance or differentiation from other reactions.
In this study of inpatients at risk for TACO (age ≥ 50 years) receiving 1 red blood cell unit, cardiac biomarkers, brain natriuretic peptide (BNP), N-terminal pro-BNP (NT-proBNP), and high-sensitivity troponin were measured at baseline, 6 to 12 hours (except troponin) posttransfusion, and 18 to 24 hours posttransfusion. Primary outcome was a critical increase in biomarkers (>1.5-fold increase and supranormal) at 18 to 24 hours.
Fifty-one patients were analyzed; 29% had cardiovascular disease, 73% had one or more cardiac risk factors, and 50% took cardiac or antihypertensive therapies. Although eight (16%) developed an increase in systolic pressure of at least 30 mmHg and four (8%) reported dyspnea and/or cough, none had TACO. At baseline, BNP level was more than 100 ng/L in 59% and NT-proBNP was more than 300 pg/mL in 83%. A total of 25% had a BNP critical increase, 33% had a NT-proBNP critical increase, and 2% had a troponin critical increase at 18 to 24 hours. Overall, 38% had at least one biomarker critical increase and NT-proBNP/BNP concordance was 84%. An increase in the NT-proBNP (>1.5-fold increase and >300 pg/mL) at 18 to 24 hours was the commonest biomarker change.
An increase of the NT-proBNP at 18 to 24 hours may be the preferred surrogate marker for identifying a patient experiencing physiologic difficulty in handling the volume challenge. Larger studies are needed to clarify the risk of TACO for a given pretransfusion biomarker profile and the correlation between TACO and increase in biomarkers after transfusion.
输血相关循环超负荷(TACO)是严重反应的主要原因。关于TACO,作为预测指标的生物标志物、其最具信息量的检测时间、显著或与其他反应相区分的阈值等方面知之甚少。
在这项针对有TACO风险的住院患者(年龄≥50岁)输注1个红细胞单位的研究中,在基线、输血后6至12小时(肌钙蛋白除外)以及输血后18至24小时测量心脏生物标志物、脑钠肽(BNP)、N末端脑钠肽前体(NT-proBNP)和高敏肌钙蛋白。主要结局是在18至24小时时生物标志物出现临界升高(升高>1.5倍且高于正常范围)。
分析了51例患者;29%患有心血管疾病,73%有一项或多项心脏危险因素,50%接受心脏或抗高血压治疗。尽管8例(16%)收缩压升高至少30 mmHg,4例(8%)报告有呼吸困难和/或咳嗽,但无一例发生TACO。基线时,59%的患者BNP水平超过100 ng/L,83%的患者NT-proBNP超过300 pg/mL。在18至24小时时,共有25%的患者BNP出现临界升高,33%的患者NT-proBNP出现临界升高,2%的患者肌钙蛋白出现临界升高。总体而言,38%的患者至少有一项生物标志物临界升高,NT-proBNP/BNP的一致性为84%。在18至24小时时NT-proBNP升高(升高>1.5倍且>300 pg/mL)是最常见的生物标志物变化。
在18至24小时时NT-proBNP升高可能是识别在应对容量挑战时出现生理困难患者的首选替代标志物。需要开展更大规模的研究来阐明给定输血前生物标志物谱下TACO的风险以及TACO与输血后生物标志物升高之间的相关性。